What is RVPH's dilution risk score?

RVPH has a latest available DilutionScore record of 74/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for RVPH, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for RVPH?

DilutionWatch tracks 25 SEC filing types for RVPH including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect RVPH shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For RVPH, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for RVPH tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for RVPH. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

RVPH Dilution Risk Score: 74/100 (HIGH)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

65

📊 Float Risk

25

⚠️ Warrant Exposure

90

🔄 Convertible Debt

15

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 53%

🔄 Reverse Split model est. 65%

• 50-day avg $0.72 below $1 exchange minimum

• 8 months cash with weak price

📜 Warrant Exercise model 60%

• Massive warrant overhang: 133% of shares outstanding

• Warrant risk score very high (90/100)

💰 Capital Raise model 15%

• Under 12 months cash (8mo)

🔔 Track RVPH — Get forecast alerts →

Market Data

Market Cap$5.36M

Shares Outstanding13.11M

Float11.38M

Cash$19.89M

Debt$144.1K

Short InterestN/A

Institutional Holdings

QoQ: ↓ 97.6% shares (2026Q1 vs prior)

5 institutional holders · 391.5K shares

#1 MORGAN STANLEY 341.4K shares

#2 Corient Private Wealth LLC 38.0K shares

#3 Purpose Unlimited Inc. 8.1K shares

+ 2 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest408.8K

Days to Cover3.4

% of Float3.6%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2021-12-31

8-K 8K EVENT 2025-12-23

4 INSIDER TRANSACTION 2025-12-19

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual RVPH Dilution Snapshot

Reviva Pharmaceuticals Holdings, Inc. (RVPH) has a DilutionScore of 74/100, rated High dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 17.5M.
Recent SEC activity tracked for RVPH: xbrl on 2026-06-30; 8-K on 2025-12-23; 4 on 2025-12-19.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.